Analyst Ratings for Pacific Biosciences of California (pacb)

pacb Rating Summary

pacb Price Target Summary

* Over Last 12-Mos
  |   Expand Research on pacb
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $10.25 (+21.2%) * Over Last 12-Mos
Rating Score: 4.6 / 10   Percentile Rank: 49%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/27/2016 CL King New Coverage Buy
(N/A)
11.00
(N/A)
8.13 8.46 4.06% Details
4/15/2016 First Analysis New Coverage Overweight
(N/A)
11.00
(N/A)
8.74 8.46 -3.2% Details
Like PACB Ratings? Also take a look at SFLY, RHHBY, GSK, RMBS

PACB Ratings News